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Spatial compartmentalization and tissue-selective loca-
lization of T lymphocytes to the skin are crucial for
immune surveillance and the pathogenesis of various
disorders including common in£ammatory diseases
such as atopic dermatitis or psoriasis, but also malig-
nancies such as cutaneous Tcell lymphomas. Cutaneous
recruitment of lymphocytes is a highly complex pro-
cess that involves extravasation, migration through the
dermal connective tissue, and eventually, localization
to the epidermis. An intertwined network of cytokines
and chemokines provides the road signs for leukocyte
migration, while various adhesion receptors orchestrate
the dynamic events of cell-cell and cell-substrate inter-
actions resulting in cutaneous localization of Tcells. Se-
lectively targeting the functions of molecules involved
in this interplay promises exciting new therapeutic op-
tions for treating in£ammatory skin disorders. J Invest
Dermatol 121:951 ^962, 2003
T
issue-speci¢c localization of T lymphocytes is a re-
quirement for immune surveillance in the skin and
plays a key role in the pathogenesis of various dis-
eases. Tcells have been implicated in the pathogenesis
of benign in£ammatory skin conditions, such as
psoriasis, various forms of eczema, vitiligo, alopecia areata,
drug-induced eruptions, or lichen planus (Groves and Kupper,
1996; Robert and Kupper, 1999), but are also pivotally involved
in cutaneous malignancies, such as T cell lymphomas (Knowles
and Halper, 1982). Insight into mechanisms of T cell recruitment
to the skin is therefore essential for an understanding of the
pathophysiology and potential therapies of these and other skin
disorders. Given that tissue-selective tra⁄cking of T lymphocytes
is mediated by a multitude of complex and intricate interactions
of cytokines and chemokines with adhesion receptors (Kunkel
and Butcher, 2002), described here according to their molecular
nature and function, these molecules are crucial for the site-
speci¢c recruitment and functions of T cells.
ADHESION MOLECULES: MOLECULAR LADDERS FOR
CUTANEOUS LYMPHOCYTE RECRUITMENT
Rolling as the initial step of lymphocyte localization: the
¢rst contact The ¢rst steps of T cell localization to all tissues
include leukocyte tethering and rolling on the vessel wall
(schematically depicted in Fig 1), transient adhesive interactions
that are mediated primarily by selectins (Groves et al, 1991;
Shimizu et al, 1991; von Andrian et al, 1991; Smith et al, 1993;
Springer, 1994; Butcher and Picker, 1996). Selectins are single-
chain transmembrane adhesion molecules characterized by a
lectin-like domain that binds to carbohydrate ligands displayed
on glycoprotein sca¡olds (Feizi, 2001; Varki, 1994; Ley, 2001).
Activated endothelial cells, on the one hand, rapidly mobilize
P-selectin (CD62P) to the cell surface (Bonfanti and Furie, 1989;
McEver and Beckstead, 1989), while expression of E-selectin
(CD62E) is transcriptionally regulated (Cotran and Gimbrone,
1986; Bevilacqua and Stengelin, 1989). Chemokine interactions
with their receptors can modulate the functions of selectins very
rapidly (Grabovsky et al, 2002). The pivotal role of P- and
E-selectin for leukocyte rolling has been con¢rmed by a large
variety of experimental approaches interfering with adhesive
interactions of selectins and their carbohydrate ligands (Carlos
and Harlan, 1994; Todderud et al, 1997). A number of studies
have demonstrated overlapping and mutually compensating
functions of selectins (Labow et al, 1994; Jung and Ley, 1999;
Collins et al, 2001). Consistent with these studies, a function-
blocking antibody speci¢cally directed against E-selectin did not
alleviate psoriasis in a recent clinical trial (Bhushan et al, 2002).
This clinical observation suggested that some selectin-mediated
functions may be redundant and that interfering with a single
selectin alone is not su⁄cient to interrupt the in£ammatory
chain in certain diseases. This notion is further supported by
efomycines, recently discovered speci¢c small-molecule inhi-
bitors of both E- and P-selectin functions. Blocking both E-
and P-selectin by efomycine M signi¢cantly inhibited rolling
of T lymphocytes on cutaneous microvessels and markedly
alleviated chronic in£ammatory skin conditions in a T cell-
mediated murine model of psoriasis as well as in human
psoriatic skin transplanted onto scid/scid mice (Sch˛n et al,
2002).
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On the other hand, naive and central memory T cells express
L-selectin (CD62L) that binds to endothelial cell selectin ligands
(Fig 1). L-selectin ligands such as PNAd may be induced on
dermal endothelial cells in chronic in£ammatory skin disorders
(Lechleitner et al, 1999; Hwang and Fitzhugh, 2001). The topogra-
phic distribution of L-selectin on the tips of microvilli of rolling
leukocytes appears to be important for contact formation with
endothelial ligands (Fors et al, 2001). It is thought that shedding
of L-selectin, a proteolytic process mediated by metalloproteases
(Condon et al, 2001; Zhao et al, 2001), also plays a role for proper
lymphocyte rolling (Hafezi-Moghadam and Ley, 1999). Inhibi-
tion of L-selectin shedding results in increased LFA-1/intercellular
adhesion molecule-1 (ICAM-1)-mediated ¢rm adhesion and, con-
secutively, transmigration of lymphocytes (Hafezi-Moghadam
et al, 2001), suggesting a regulatory function of the shedding
process.
In addition,T cells express transmembrane glycoproteins bear-
ing sialyl-LewisX (sLeX) moieties, which function as E- and P-
selectin ligands (Varki, 1994). T lymphocytes localizing to the
skin express the sLeX-bearing cutaneous lymphocyte-associated
antigen (CLA), arising from specialized glycosylation of
P-selectin glycoprotein ligand-1 (CD162) (Fuhlbrigge et al, 1997),
which is thought to be involved in tissue-speci¢c localization of
cutaneous T cells (Picker et al, 1990, 1991). CLA-bearing T lym-
phocytes appear to extravasate preferentially through the en-
dothelium of the super¢cial dermal plexus (Kunstfeld et al, 1997)
suggesting topographic specialization of microvascular endothe-
lial cells within the skin.
In addition to selectin-mediated rolling, very late antigen-4
(VLA-4, a4b1-integrin, CD49d/CD29), a heterodimeric adhesion
receptor of the integrin family that binds to the Ig-superfamily
adhesion molecules vascular cell adhesion molecule-1 (VCAM-1)
and mucosal addressin cell adhesion molecule-1 (Fig 1), has also
been found to mediate rolling of certain leukocyte subsets (Berlin
et al, 1995; Reinhardt et al, 1997; Singbartl et al, 2001).This involve-
ment in leukocyte rolling is exerted in addition to its known
function for ¢rm adhesion (below) and is due, at least in part, to
the topographic presentation of VLA-4 on microvilli of roll-
ing cells, thus enabling the ¢rst contact to endothelial-bound
counterreceptors (Berlin et al, 1995). VLA-4 a⁄nity is thought
to be rapidly upregulated upon T cell stimulation via signaling
through the p56lck Src kinase pathway (Feigelson et al, 2001), a
process that may be important for the transition from rolling to
¢rm adhesion. Although some aspects of the interplay of VLA-
4- and selectin-mediated adhesive interactions involved in leuko-
cyte rolling still remain to be unraveled, it appears that their
relative contributions are in£uenced by tissue- and (micro)environ-
ment-speci¢c factors and that there is some redundancy in their
functions. In cutaneous in£ammation in rats, all three receptors,
E-selectin, P-selectin, and VLA-4, were required for rolling of
memoryT lymphocytes (Issekutz and Issekutz, 2002).
Firm adhesion and extravasation: commitment to leave the
circulation Stimulatory e¡ects exerted by a growing number
of chemokines and other mediators initiate the subsequent
adhesive steps of cutaneous lymphocyte localization (Sch˛n and
Ruzicka, 2001; Homey et al, 2002). After transient, selectin-
and VLA-4-mediated rolling, leukocytes become activated (as
outlined below) and ¢rmly attach to the endothelium through
adhesion of b2-integrins, including LFA-1 (CD11a/CD18, aLb2)
or Mac-1 (CD11b/CD18, aMb2), to immunoglobulin superfamily
members, such as ICAM-1 (CD54) (Dustin et al, 1986; Gri⁄ths
Figure1. Adhesive interactions and chemokine-driven activation involved in lymphocyte extravasation in the skin. (Bottom) Key steps of
interactions with the endothelial lining resulting in extravasation of lymphocytes. (Top) Selected adhesion molecules which mediate these events.
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et al, 1989) (Fig 1). This mechanism appears to be of prime
importance in various in£ammatory skin conditions (Grabbe
et al, 2002). In addition, b1-integrins and their ligands, such as
the a4b1/VCAM-1 pair, are involved in leukocyte-endothelial
cell binding (Groves et al, 1993). Proin£ammatory cytokines,
including interferon-g, tumor necrosis factor-a, and interleukin
(IL)-1 can increase T cell localization to in£ammatory sites
through induction of ICAM-1 and VCAM-1 (Gri⁄ths et al,
1989; Barker et al, 1990; Groves et al, 1993; Petzelbauer et al, 1994).
It is possible that additional mechanisms contribute to ¢rm
adhesion and endothelial transmigration of lymphocytes, similar
to a novel mechanism proposed for the aEb7-integrin within
the intestinal lamina propria (Strauch et al, 2001), but such
mechanisms in the skin remain to be unraveled.
Dermal localization: ¢nal destination for most cutaneous
lymphocytes Once extravasated at cutaneous sites, lympho-
cytes utilize b1-integrins to bind to and transmigrate through
the dermal extracellular matrix (schematically depicted in
Fig 2). These extracellular matrix receptors include the a1b1-,
a2b1-, and a5b1-integrins that bind to various extracellular
matrix components such as collagen type I, ¢bronectin,
chondroitin sulfate, laminin, or hyaluronans (Konter et al, 1989;
Hemler, 1990; Hynes, 1992). In many in£ammatory or malignant
skin disorders dermal lymphocytes outnumber epidermal
lymphocytes, suggesting that only a minority of in¢ltrating T
cells have acquired the molecular armory to migrate into the
cutaneous epithelium. Given that composition, ¢bril diameter,
and three-dimensional arrangement of extracellular matrix
molecules show site-speci¢c variation (e.g., papillary dermis,
reticular dermis, perivascular, or periadnexal areas may provide
speci¢c microenvironments) and may be altered profoundly in
in£ammatory states (Berthod et al, 2001), it appears likely that
tissue-speci¢c leukocyte localization and the distribution pattern
characteristic for certain in£ammatory skin disorders is modu-
lated, at least in part, by such factors. Nevertheless, there is no
direct evidence thus far to corroborate these hypotheses.
In addition to b1-integrins, CD44, a hyaluronate receptor
(Camp et al, 1993), and LFA-1, which may interact with an ‘‘adhe-
sive path’’ formed by interstitial ICAM-1 (Nickolo¡, 1988), appear
to facilitate dermal localization of Tcells. Binding to components
of the epidermal basement membrane, such as collagen type IV
and laminin, again appears to be mediated by b1-integrins, in-
cluding a1b1, a2b1, a3b1, and a6b1 (Hynes, 1992). This adhesive in-
teraction may be enhanced by keratinocyte-derived mediators,
such as IL-7 (Wagner et al, 1999). In addition, T cells may utilize
the a3b1-integrin to bind to epiligrin within the basement mem-
brane (Wayner et al, 1993).
EPIDERMAL T cell localization: destination for selected
few In contrast to endothelial transmigration and dermal
localization, we know relatively little about epidermal locali-
zation of T cells (schematically depicted in Fig 2). The epidermis
of the skin is a multilayered, strati¢ed, and polarized epithelium,
whose di¡erent layers show distinct stages of di¡erentiation and
surface antigen expression. Another level of complexity is added
by profound changes of the epidermal di¡erentiation pattern
under in£ammatory conditions impacting on the ability of
lymphocytes to localize to the epidermis. As a consequence,
epidermal localization of lymphocytes appears to be a rather
Figure 2. Overview of cellular events involved in dermal and epidermal localization of cutaneous lymphocytes. Similar to Fig 1, the bottom
shows cellular interactions of in¢ltrating lymphocytes with resident extracellular matrix components and cells, whereas the top represents adhesion mole-
cules involved in these interactions.
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complex process in itself, and certain lymphocyte subsets may
speci¢cally localize only to particular layers of the epidermis.
This is, at least to some extent, re£ected by the expression
pattern and spatial distribution of adhesion molecules involved
in interactions with lymphocytes.
Although many extracellular ligands for b1-integrins are not
expressed beyond the epidermal basement membrane (Konter et
al, 1989), b1-integrins have been implicated in T cell epidermo-
tropism based upon expression by intraepidermal T lymphocytes
(Sterry et al, 1992). An example is the a1b1-integrin, whose
expression by lymphocytes appears to be associated with epider-
motropic forms of cutaneous T cell lymphoma, but whose func-
tional contribution to the process of epidermotropism remains
unclear (Bank et al, 1999).
Induced by proin£ammatory cytokines, there is epidermal
de novo expression of ICAM-1 in in£ammatory skin disorders,
such as psoriasis (Dustin et al, 1988; Gri⁄ths et al, 1989). Indeed,
in vitro studies suggested that ICAM-1/LFA-1 interactions mediate
binding of activated T cells to in£amed epidermis (Kashihara-Sa-
wami and Norris, 1992). Given that ICAM-1 is induced primarily
in basal keratinocytes upon in£ammatory stimuli, it appears to be
involved in the initial steps of epidermal T cell localization just
beyond the epidermal basement membrane. Nevertheless, this
may not be the only mechanism, because constitutive epidermal
expression of ICAM-1 in transgenic mice did not result in spon-
taneous epidermal Tcell in¢ltration (Williams and Kupper, 1994),
and expression and spatial distribution of ICAM-1 and LFA-1 do
not correlate in many cases of epidermotropic lymphocyte in¢l-
tration (Gri⁄ths et al, 1989; Olivry et al, 1995). In addition, the
interaction of LFA-1 expressed by lymphocytes with ICAM-3,
which is constitutively expressed by epidermal keratinocytes,
may be involved in epidermal T cell localization (Gri⁄ths et al,
1995).
The recently identi¢ed glycoprotein lymphocyte endothelial-
epithelial cell adhesion molecule (LEEP-CAM), whose ligand
on T lymphocytes has not been identi¢ed yet, may also be in-
volved in epidermal T cell localization (Shieh et al, 1999). The
LEEP-CAM molecule, a 90- to 115-kDa cell surface glycopro-
tein, is a novel receptor mediating T cell adhesion to epithelial
cells in static cell-to-cell adhesion assays in vitro (Shieh et al,
1999). It is expressed constitutively in the suprabasal epidermal
layers, but is not expressed on T cells. Both its expression pattern
and its adhesive functions in vitro make LEEP-CAM an interest-
ing candidate molecule for mediating epidermal T cell localiza-
tion. Because LEEP-CAM is expressed exclusively within
suprabasal epidermal layers both in normal and in in£amed skin
(Shieh et al, 1999), it appears to be the ¢rst adhesion receptor
known thus far to preferentially mediate suprabasal localization
of T cells.
Another player contributing to epidermal localization of cer-
tainTcell subsets is the aE(CD103)b7-integrin, which is expressed
by the vast majority of intestinal intraepithelial T lymphocytes
(Parker et al, 1992) and is thought to contribute to localization of
di¡usely distributed T cell subsets to the mucosal epithelium
through binding to E-cadherin (Cepek et al, 1994; Karecla et al,
1995). Indeed, when integrin aE(CD103)-de¢cient mice were stu-
died, they exhibited a reduced number of mucosal intraepithelial
T cells (Sch˛n et al, 1999). Nevertheless, there is growing evidence
that aE(CD103)b7 functions are not restricted toTcells within the
intestinal mucosa, but extend to intraepithelial T lymphocytes in
other tissues, whose epithelia express E-cadherin, the ligand for
aE(CD103)b7 (Agace et al, 2000). Putative alternative ligand(s)
for aEb7 on epithelial (Brown et al, 1999) and endothelial cells
(Strauch et al, 2001) have been proposed but not positively identi-
¢ed yet. In the skin, expression of aE(CD103)b7 has been demon-
strated on epidermal T lymphocytes in some forms of
in£ammatory disorders (de Vries et al, 1997; Walton et al, 1997)
and cutaneous T cell lymphomas (Simonitsch et al, 1994; Schech-
ner et al, 1999). In a recent study, preferential expression of
aE(CD103)b7 was demonstrated on basal and suprabasal epider-
mal CD8þ T cells within psoriatic lesions, consistent with the
expression of its ligand, E-cadherin (Pauls et al, 2001), and there
is no association of aEb7 expression with expression of the che-
mokine receptor CCR4, which is expressed preferentially on der-
mal but not epidermal Tcells (Rottman et al, 2001). Expression of
aE(CD103)b7 was detected on very few dermal Tcells in psoriatic
lesions as well as in the peripheral blood. Thus, aE(CD103)b7 ap-
pears to be induced on CD8þT cells in situ upon entering the
epidermis, consistent with the focal expression of transforming
growth factor-b1 directly underneath the epidermis. In further
support of an involvement inTcell epidermotropism, aE(CD103)b7
could be speci¢cally upregulated by transforming growth factor-
b1 on CD8
þ T cells where it mediated adhesion to psoriatic
epidermis as well as to cultured keratinocytes (Pauls et al, 2001).
CYTOKINES AND CHEMOKINES:THE ROAD SIGNS
FORT CELLTRAFFICKING
T cell tra⁄cking does not only involve membrane-bound adhe-
sion molecules but also a variety of soluble or membrane-borne
chemotactic factors. A tissue-speci¢c close functional interaction
between such factors and adhesion molecules is a prerequisite for
localization of lymphocytes to in£amed tissues. These factors
include chemokines, small polypeptides whose biologic role in
various tissues and disorders is a hot area of actively ongoing
research. Presumably emerging during phylogenesis as a system
to mediate innate immune cell tra⁄cking and cell movement
during morphogenesis, repeated gene duplication, and modi¢ca-
tion established a rich repertoire of chemokines and their respec-
tive receptors in more advanced vertebrate phyla. Selective
pressure imposed on host defense by unique pathogen-commen-
sal microbe relationships created a robust system of overlapping
ligands and receptors that protects the host (Gerard and Rollins,
2001). This system is particularly well suited to complement the
molecular ladder in the process of lymphocyte recruitment pro-
vided by adhesion molecules for at least three reasons: First, che-
mokines exist as a large multigene family, and the use of distinct
chemokines at speci¢c anatomic sites contributes to speci¢city of
leukocyte recruitment. Second, they act via G-protein-coupled
receptors that are known to mediate rapid cellular responses.
Third, their association with glycosaminoglycans allows e⁄cient
presentation at the luminal surface of the endothelium (Ebnet
and Vestweber, 1999).
The known chemokine system in humans currently comprises
some 50 ligands and 20 G-protein-coupled receptors. Structu-
rally, the ligands can be divided into two major subfamilies on
the basis of the arrangement of the two N-terminal cysteine re-
sidues, depending on whether they have an amino acid between
them (CXC) or are adjacent (CC). Two other classes of chemo-
kines comprise lymphotactin (C), lacking cysteines one and three
of the typical chemokine structure, and fraktalkine (CX3C) with
three amino acids between the ¢rst two cysteines (Zlotnik and
Yoshie, 2000). Constitutive and inducible chemokines have been
described: The former are involved in basal leukocyte tra⁄cking
and forming the architecture of secondary lymphoid organs,
whereas the latter recruit leukocytes in response to physiologic
stress. Expression of inducible chemokines can be elicited by al-
most any stimulus that alters cellular homeostasis, and mRNA-
encoding-induced chemokines can increase over 300-fold within
a few hours of activation. Thus, inducible chemokines can be re-
garded as a vertebrate cellular ‘‘SOS response’’ that recruits leuko-
cytes to areas of tissue injury (Gerard and Rollins, 2001).
Expression of chemokines and their receptors can easily be
documented in disorders associated with leukocyte in¢ltration.
Nevertheless, to date the only human disease for which there is
a clear-cut evidence for an association with the chemokine system
is HIV infection. In all other cases, de¢nitive roles for chemokines
in human pathology either are indirect or have been infer-
red from animal models.With this notion in mind, data on the
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involvement of the chemokine system in lymphocyte recruit-
ment to the skin are now discussed.
Chemokines mediate transition of T cells from rolling to
¢rm adhesion As described above, the ¢rst step of T cell
recruitment to the skin is the transition into a rolling motion
along the vessel wall, mediated by short-lived interactions
between selectins and their ligands. Subsequently, T cells must
rapidly arrest on the vessel wall after a short period of rolling
and resist detachment by disruptive shear £ow, a task exclusively
mediated by integrins. A unique feature of integrins is that their
activity is dynamically regulated independent of their level of
surface expression (Hynes, 1992). Immune cells are therefore
capable of constantly adapting their adhesive behavior toward
ligands on matrix surfaces (Shimizu et al, 1999). To avoid non-
speci¢c sticking to blood vessels, circulating leukocytes maintain
their integrins in largely nonadhesive states. Once captured by
selectins, rolling leukocytes come in close contact with a
relatively wide area of endothelium, which can be sampled for
activation signals. In situ activation of integrins by endothelium-
displayed signals results in increased integrin avidity and serves
as a reversible checkpoint for tethered leukocytes to successfully
arrest on target endothelial sites before initiating diapedesis.
Activation of integrin avidity can take place within fractions of
seconds (Campbell et al, 1998; Grabovsky et al, 2000) and is
triggered by endothelium-displayed chemokines (Mackay, 2001).
The rapid nature of chemokine stimulation of integrin-
mediated adhesion under shear £ow is ideally suited to bridge
selectin-mediated rolling to ¢rm integrin-mediated adhesion in
various multistep adhesive cascades (Bargatze et al, 1995; Johnston
et al, 1996).
It is overall well accepted that chemokines can contribute to
leukocyte capture on the endothelial cell wall through triggering
the avidity of leukocyte integrins. In apparent contrast to this
function, a novel, antiadhesive, G-protein-independent, downre-
gulatory activity of chemokines has been described recently that
results in destabilizing L-selectin-mediated leukocyte rolling
(Grabovsky et al, 2002). Whether or not chemokines may also
have antiadhesive properties mediated via E- or P-selectin is cur-
rently not known.
Although chemokines released into the circulation are ex-
pected to activate leukocyte integrins systemically and transiently
(Constantin et al, 2000; Chan et al, 2001), integrin activation by
serum chemokines at locations remote from the target is unlikely
to control leukocyte tra⁄cking to speci¢c sites. Instead, this pro-
cess is determined by chemokines displayed in situ. Retention of
soluble chemokines at the endothelial surface and presentation to
leukocytes can be achieved by the thick endothelial glycocalyx
which is rich in proteoglycans. These could serve as anchoring
structures for chemokines, because the latter contain binding sites
for heparin/heparan sulfate glycosaminoglycans (Anderson and
Shaw, 1993; Proudfoot et al, 2001). The chemokines displayed are
transported to the respective sites by means of transcytosis; this
has been demonstrated for chemokines at intestinal and cuta-
neous sites alike (Middleton et al, 1997; Baekkevold et al, 2001;
Homey et al, 2002).
The establishment of integrin-mediated ¢rm adhesion of leu-
kocytes to endothelial cells results from a rapid series of sequen-
tial and partially overlapping steps, only some of which require
active participation of chemokines. The ¢rst step in avidity gen-
eration involves preformed integrin clustering on the leukocyte
surface (Lub et al, 1997), preformed conformational states confer-
ring variable a⁄nity to ligands (Feigelson et al, 2001), or ligand-
driven integrin clustering events (Yauch et al, 1997). Subsequently,
upon encounter of the proper chemokine at the integrin-
mediated contact, conformational changes in integrin ligand-
binding domains can be induced. The molecular basis of integrin
a⁄nity regulation is still somewhat obscure. It is currently
thought that disruption of key ionic interactions between mem-
brane proximal cytoplasmic sequences on integrin subunits are
involved (Takagi et al, 2001). Concomitant with chemokine-
induced conformational alterations, integrin microclustering
can be triggered by chemokines through e¡ectors acting via G-
protein-coupled receptors (Constantin et al, 2000; Grabovsky et al,
2000). In addition to chemokines, endothelial ligands to integrin-
associated receptors may further enhance integrin avidity at
dynamic contacts. An example for this e¡ect is the enhance-
ment of VLA-4-dependent lymphocyte adhesiveness to VCAM-1
under shear £ow by rapid interactions between CD47 (a b3-
integrin-binding pentaspan) and endothelium-associated CD47
ligands like thrombospondin and signal regulatory protein 1a
(SIRP1a) (Ticchioni et al, 2001). Next, integrins distal to the ori-
ginal endothelial adhesive zone established by the arrested leuko-
cyte undergo patching in response to chemokine-triggered
signals, again mediated via G-protein-coupled receptors (Con-
stantin et al, 2000). Finally, integrin outside-in signaling is pro-
moted at the leukocyte contact with the endothelial integrin
ligands through anchorage to the actin cytoskeleton and a build-
up of integrin complexes. These ‘‘adhesiosomes’’ link integrin oc-
cupancy to actin remodeling and microtubule reorganization,
which in turn are key regulatory systems in cell spreading and
contractility on endothelial surfaces (Sanchez-Madrid and del
Pozo, 1999).
The general mechanisms mediating the transition from rolling
to ¢rm adhesion appears to be remarkably well preserved among
di¡erent leukocyte types. It is the expression pattern of chemo-
kines and their receptors which determines the type of cell that
is attracted. This pattern is regulated under the in£uence of the
local cytokine milieu: interferon-g induces a number of chemo-
kines that act to recruit monocytes, neutrophils, and T-helper-1
(Th1) lymphocytes, whereas IL-4 and IL-13 induce CCL2,
CCL11, CCL17, and CCL22, which leads to aTh2-dominated pat-
tern of cell recruitment (seeTable I), with IL-4 and interferon-g
capable of antagonizing each other’s chemokine induction (Bone-
cchi et al, 1998). Under most circumstances, only activated e¡ector
lymphocytes respond to in£ammatory chemokines, because naive
cells typically do not express the respective receptors (Syrbe et al,
1999). Similar to the chemokines, chemokine receptors, too, are
regulated by a variety of in£ammatory cytokines. Examples com-
prise the induction and maintenance of T cell expression of
CCR1, CCR2, and CXCR3 by IL-2 or suppression of CCR5
expression by IL-10.
Given the redundancy within the chemokine system, it is not
surprising that numerous chemokines exhibit roles in leukocyte
tra⁄cking which overlap at least in part (seeTable I).With regard
to T cell tra⁄cking to in£amed skin, recent studies have high-
lighted the key role of two particular pathways, namely, the inter-
actions between the chemokines CCL17 and CCL27 with their
respective receptors, CCR4 and CCR10 (Table I). Increased ex-
pression of CCR4 was demonstrated in some forms of cutaneous
T cell lymphoma and may play a role in localization through
interaction with its ligands, TARC/CCL17 and MDC/CCL22
(Ferenczi et al, 2002). In a mouse model for delayed-type hyper-
sensitivity, a supportive role of both CCR4 and CCL27 for Tcell
homing to the skin was demonstrated (Reiss et al, 2001). CCL27 is
a skin-associated CC chemokine primarily expressed by basal
keratinocytes in normal epidermis and throughout the epidermis
in skin lesions from patients with atopic eczema as well as psor-
iasis (Kakinuma et al, 2003), fromwhere it is released into the der-
mis; it is also seen on both the abluminal as well as the luminal
sides of endothelial cells of the super¢cial dermal plexus (Homey
et al, 2002). Skin-in¢ltrating lymphocytes are characterized by the
expression of CCR10, the receptor for CCL27. Utilizing mouse
models, it has recently been demonstrated that lymphocytes can
be attracted by intracutaneous injection of CCL27 and that lym-
phocyte recruitment to the skin is impaired following neutraliza-
tion of CCL27-CCR10 interactions (Homey et al, 2002). The role
of CCR4 in T cell homing to the skin is supported by studies
investigating normal and in£amed human tissues, including sam-
ples from atopic dermatitis (Kakinuma et al, 2001; Rottman et al,
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2001; Kunkel et al, 2002). In addition, the pair CCL20/CCR6 ap-
pear to be relevant for endothelial arrest of some memoryT cells
in the cutaneous microvasculature (Homey et al, 2000a; Fitzhugh
et al, 2000).
Skin-homingTcells in humans are currently best identi¢ed by
the skin-homing receptor CLA (see above), but a monoclonal
antibody to CCR10 (Homey et al, 2002) labels only one third of
these cells, suggesting the existence of additional chemokine re-
ceptors for skin homing. Based on recent data one can assume
that at least one of the CCR4- or CCR10-mediated pathways
must be functional to e¡ectively recruit T cells to in£amed skin,
but their involvement is overlapping inasmuch that either one is
permissive (Reiss et al, 2001; Mackay, 2002).
A role for chemokines in lymphocyte transendothelial
migration and migration into the skin In contrast to
adhesion molecules, whose functions can be assigned to the
di¡erent phases of lymphocyte recruitment to the skin, the
exact role of chemokines throughout this process is rather
di⁄cult to de¢ne. This is, at least in part, due to the fact that
chemokines tend to form gradients: Being highly basic proteins,
secreted chemokines are immobilized on cells or extracellular
matrix surfaces by interacting with negatively charged glyco-
saminoglycans. Of note, chemokines show di¡erences regarding
a⁄nities to di¡erent types of glycosaminoglycans (Kuschert et al,
1999). The latter can vary depending on cell type, location, and
in£ammatory status. Selective immobilization at a given site
may therefore be a regulatory step determining chemokine
function in certain tissues or in£ammatory states. In addition,
oligomerization of chemokines occurs on glycosaminoglycans
and may provide a mechanism for gradient formation
(Hoogewerf et al, 1997). Chemokines near their sites of pro-
duction may form oligomers of higher order on endothelial or
extracellular matrix glycosaminoglycans, thereby creating and
preserving higher chemokine concentrations near the initiating
in£ammatory or tra⁄cking stimulus. This causes the leukocyte
to move up the chemokine gradient and toward the relevant
site (Olsen and Ley, 2002). In con¢rmation of this concept, it
has indeed be demonstrated that leukocytes are capable to
sense several distinct chemokine gradients and can navigate
accordingly (Foxman et al, 1999).
The process of transendothelial migration is still poorly under-
stood. Transendothelial migration comprises the crossing of
adherent blood-borne cells in a nonproteolytic manner at or
near their original contact site with the endothelium. Using
cytokine-activated endothelial monolayers reconstituted with
chemokines it has been demonstrated that endothelial-bound
chemokines promote massive lymphocyte transendothelial mi-
gration (Cinamon et al, 2001). This process requires continuous
exposure of lymphocytes to £uid shear. Thus, apical endothelial
chemokines, besides triggering lymphocyte capture to the en-
dothelial surface, are also relevant regarding postarrest events that
promote lymphocyte transendothelial migration (Cinamon et al,
2001).
Once they have reached the skin, in¢ltrating lymphocytes can
navigate along established chemokine gradients as outlined above.
These gradients may vary among chemokines depending on their
respective sources. With regard to the two apparently most im-
portant chemokine pathways for T cell homing to the skin,
namely the CCL17^CCR4 (which also binds to CCL22) and the
CCL27^CCR10 pathways, these sources di¡er: On the one hand,
CCL17 is constitutively expressed and hyperinducible on cuta-
neous venules (and some other systemic venules), and upregula-
tion of constitutive expression is also observed in some human
¢broblast and keratinocyte cell lines (Yu et al, 2002). On the other
hand, CCL27 is produced by keratinocytes but neither ¢broblasts
nor dermal microvascular endothelial cells (Homey et al, 2000b,
2002). CCL27 is therefore most likely secreted into the papillary
dermis, immobilized on the extracellular matrix, and displayed
on the surface of endothelial cells following transcytosis (Homey
et al, 2002). Thus, it might be hypothesized that the CCL17^
CCR4 pathway recruits lymphocytes as far as into the dermis,
whereas the CCL27^CCR10 pathway may guide them all the
way up into the epidermis. In line with this hypothesis are
the observations that CCR4þ T cells preferentially populate
the dermal compartment and not the epidermis (Rottman et al,
2001), while CCR10þ lymphocytes were detected within both
dermis and epidermis (Homey et al, 2002). Nevertheless, there is
experimental evidence that blockade of CCL27 alone is su⁄cient
to block cutaneous in£ammation (Homey et al, 2002), suggesting
a complex interaction of di¡erent chemokines.
EMERGING MOLECULARTARGETS: BRINGING
UNDERSTANDING OF CUTANEOUS T CELL
RECRUITMENT TO PATIENTS
The concept that Tcells play a pivotal role in many in£ammatory
disorders, such as psoriasis, contact dermatitis, or atopic der-
matitis, has been corroborated in human diseases as well as in
Table I. Chemokines and their receptors involved in lymphocyte recruitment
Ligand(s) Receptor(s) Cellular distribution Role in T cell tra⁄cking
CXCL9, 10, 11 CXCR3 T cells (Th14Th2), B cells, NK cells Recruitment of lymphocytes toTh1-type
in£ammatory sites including CNS and intestine
CXCL12 CXCR4 Progenitor cells, lymphocytes, monocytes,
macrophages, DCs
Thymocyte homing, early recruitment of T cells to
in£amed lung
CXCL13 CXCR5 B cells, memoryT cells Lymphocyte migration to B cell follicles
CXCL16 CXCR6 MemoryT cells Recruitment of Th1 cells to in£amed sites
CCL1, 4 CCR8 Th2 cells T cell recruitment toTh2-type in£ammatory sites
CCL3, 4, 5 CCR5 Progenitors,Th1 cells, monocytes, macrophages, DCs Recruitment toTh1-type in£ammatory sites
CCL3, 5, 7, 14, 15, 16, 23 CCR1 MemoryT cells Recruitment to most types of in£ammation
CCL5, 7, 8, 13, 15, 24, 26 CCR3 Eosinophils, basophils, mast cells,T cells Recruitment toTh2-type in£ammatory sites including
lung and skin
CCL17, CCL22 CCR4 Tcells Recruitment of Tcells (Th24Th1) to
in£ammatory sites including lung and skin,
cutaneous Tcell lymphoma
CCL20 CCR6 T cells, macrophages Endothelial arrest of some memoryT cells
CCL19, 21 CCR7 T cells, B cells, DCs Homing to secondary lymphoid organs
CCL25 CCR9 a4b7þ T cells, DCs, macrophages, thymocytes T cell homing to small intestine, thymocyte selection
CCL27 CCR10 CLAþ Tcells Tcell homing to skin
Note. Boldface denotes that these chemokines and chemokine receptors seem to be most relevant with regard toT cell recruitment to cutaneous in£ammation.
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numerous animal models (Herz et al, 1998; Sch˛n, 1999; Girolo-
moni et al, 2001; Asadullah et al, 2002a). Indeed, the number of
Tcells in¢ltrating the skin may be correlated with disease activity
which has been demonstrated most elegantly for psoriasis (Krue-
ger et al, 1995). Therefore, interfering with the multistep process
directing T cells into the cutaneous compartments appears to be
an attractive target to treat in£ammatory skin diseases, an ap-
proach that is pursued by several pharmaceutical companies.
However, there are several challenges that may make this approach
very complex and unpredictable, and this is mirrored by the fact
that most of the previous approaches were not satisfying in clin-
ical trials such as trials using the sialyl LewisX-mimetic cylexin or
an anti E-selectin monoclonal antibody (Bhushan et al, 2002).
Some examples of these challenges are:
1. Redundancy Although it was initially believed that CLA
expressed by skin-homing T cells is predominantly an E-selectin
ligand (Berg et al, 1991; Rossiter et al, 1994), it is now clear that the
carbohydrate moiety responsible for tethering and rolling of T
cells along the skin microvasculature also binds to P- (Labow
et al, 1994) and L-selectin (Jung and Ley, 1999; Collins et al, 2001).
In fact, the overlap of the selectin functions is considerable (Jung
and Ley, 1999; Labow et al, 1994). Although L-selectin is not
expressed by endothelial cells, endothelial cells of chronically
in£amed skin can express PNAd, which serves as a ligand for L-
selectin expressed by either naive or central memoryT cells. This
may allow rolling of E-selectin ligand/CLA-negativeTcells along
the skin microvasculature. Furthermore, L-selectin-mediated
rolling appears to be increasingly important in situations in
which functional E- and P-selectin ligand expression is reduced
or blocked by small molecules (Alon and Feigelson, 2002; Dwir
et al, 2002). Another possibility for E-selectin ligand-negative
T cells to roll along the endothelial lining is the formation of
clusters with activated platelets. This has been demonstrated
initially for lymph nodes (Diacovo et al, 1996, 1998) but holds
also true for the skin (Ludwig et al, 2001). Even in the complete
absence of selectins or selectin ligands residual rolling can be
mediated via the interaction of T cell-expressed VLA-4 with
endothelial VCAM-1 in the cremaster model (Jung and Ley,
1999). In vitro, however, it was found that CLA engagement
is required for using the VLA-4/VCAM-1 pathway because
the CLA/E-selectin and the VLA-4/VCAM-1 pathways were
involved sequentially (Santamaria Babi et al, 1995). Redundancy
may also be a major problem at the level of chemokine^
chemokine receptor interaction (Zlotnik and Yoshie, 2000;
Onu¡er and Horuk, 2002).
2. Speci¢city Although it has been known for a long time that
the E- and P-selectin ligand CLA is responsible for T cell
tra⁄cking into skin, interactions of E- and P-selectin with their
T cell-expressed ligands are not speci¢c for the skin. Therefore,
interfering with E- and P-selectin-mediated interactions may
result in immunosuppression in organs other than the targeted
skin such as the intestine or the lymph nodes (Lowe, 1997;
Smithson et al, 2001; Sch˛n et al, 2002). The same holds true for
chemokines, because CCR4 is also involved in leukocyte
tra⁄cking to the lung, and CCR10 binds not only CCL27
Table II. Inhibitors of selectin-function targeting lymphocyte rolling along the endothelial lining
Compound Company Status Targeted indication/comment Reference(s)
Small molecules
CY-1503 Cytel Corp. Inactive Reperfusion injury of lung and heart, ischemic liver injury, sepsis-
induced lung injury; carbohydrate sialyl LewisX analog; t1/2 10^30
min; ine¡ective in several clinical studies
Kerr et al (2000)
BMS-190394 BMS Inactive Delayed-type hypersensitivity, immune-complex arthus reaction;
structural sulfatide analog, inhibitor of E-, P-, and L-selectin; no
development has been reported since 1997
Birnbaum et al (1997)
Not known Aventis Inactive Program stopped Marinier et al (2001)
OC-229648 Ontogen Kanebo Inactive Atopic dermatitis; carbohydrate E-, P-, and L-selectin inhibitor
Efomycine M None Preclinical Psoriasis, in£ammatory bowel disease; E- and P-selectin
antagonist, e⁄cacious in animal models
Sch˛n et al (2002)
ESA-2 Novartis Inactive? Leukocyte rolling in TNFa-stimulated mouse cremaster; E-
selectin inhibitor suppresses CCL22-mediated Th2 skin homing
IC50 (E-sel) 36 mM
Biedermann et al (2002);
Bantely and Ernst (2001);
Thomson et al (1993);
Thoma et al (2001)
OJ- R9188 Nippon Organon Phase I/II Psoriasis, delayed-type hypersensitivity, ovalbumin-induced skin
in£ammation, thioglycolate-induced peritonitis; Pan selectin
inhibitor (IC50 in low mM range) with insu⁄cient response in
Phase I/II study for psoriasis
Ikegami-Kuzuhara et al (2001)
TBC-1269 Texas Biotechnology Phase I/II Psoriasis, ischemic renal failure, reperfusion heart injury, antigen-
induced airway hyperresponsiveness; e⁄cacious in open-label
study in psoriasis
Abraham et al (1999);




Protein Design Labs Phase I Bispeci¢c monoclonal antibody against E- and P-selectin Berg et al (1995);
He et al (1998)
HuDREG-200 Protein Design Labs Phase Ib Psoriasis; no results reported
EL-246 LygoCyte Preclinical E- and L selectin antibody Carraway et al (1998)
CDP-850 Celltech Phase II Psoriasis; E-selectin mAb, not e¡ective in phase II trial Bhushan et al (2002)
Others
rhPSGL-1 Ig Genetics Institute Phase II Acute myocardial infarction; stopped owing to disappointing
results from phase II study
Khor et al (2000)
LD201t1 Wyeth NeXStar Preclinical Oligonucleotide inhibitor of L-selectin binding Hicke et al (1996)
e¡ective in SCID human model (nM IC50)
Abbreviations: rhPSGL-1 Ig, recombinant human P-selectin glycoprotein ligand-1 immunoglobulin; TNFa, tumor necrosis factor-a.
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produced by keratinocytes but also CCL28 produced by
intestinal epithelial cells.
3. Unexpected e¡ects Although a prominent role of the
fucosyltransferase FucT-VII for homing and immune functions
of T cells in the skin has been demonstrated in mice, the role of
FucT-VII has been challenged in humans recently as a
nonfunctional missense mutation had no e¡ect on leukocyte
rolling along E- and P-selectin (Bengtson et al, 2002). Another
unexpected e¡ect may relate to a recently identi¢ed regulatory
activity of chemokines that results in antiadhesive, G-protein-
independent destabilization of L-selectin-mediated leukocyte
rolling (Grabovsky et al, 2002). One can hypothesize that this
novel function could result in paradoxically enhanced in£amma-
tion when chemokines are targeted. Nevertheless, no experi-
mental data have been published thus far that conclusively
demonstrate whether or not chemokines may have antiadhesive
properties under certain conditions.
As outlined above, T cell tra⁄cking during an in£ammatory
response begins with lymphocyte rolling along the vessel wall
involving predominantly E- and P-selectin expressed by the en-
dothelium with carbohydrate moieties such as sLex and CLA.
Therefore, various approaches have been taken to interfere with
this crucial initial step. As summarized in Table II, many of the
programs searching for small-molecule inhibitors of the selectin
family have been stopped, a fact that may re£ect inherent di⁄cul-
ties in targeting this very initial step. There are several reasons,
which are not mutually exclusive, why some compounds gener-
ated so far have not entered the clinic or failed in clinical trials: (1)
low IC50 values (e.g., for cylexin); (2) unfavorable pharmaco-
kinetic properties such as short t1/2 (e.g., cylexin); (3) speci¢city
for only one selectin (e.g., CDP-850) or a suboptimal combina-
tion of selectin speci¢cities (e.g., EL-246); and (4) lability of
selectin^selectin ligand interaction which is essential for allowing
short-lived lymphocyte^endothelial interactions mediating T cell
rolling (Table II).
Another approach aimed at targeting T cell rolling along the
skin microvasculature is interfering with fucosyltransferase-VII
and -IV, key enzymes in the generation of selectin^ligand carbo-
hydrate moieties. The rationale behind this approach comes from
the observation that selectin ligand activity is absent or reduced
dramatically in FucT-VII single or FucT-IV and^VII double-
knockout mice. In vivo relevance of this impaired function was
implicated by markedly reduced cutaneous in£ammatory res-
ponses in several models using animals de¢cient for one or both
enzymes (Maly et al, 1996; Weninger et al, 2000; Homeister et al,
2001; Asadullah et al, 2002b). One such approach is interfering
with expression of FucT-VII via inhibiting its transcription using
NF-kB inhibitors such as the proteasome inhibitor PS-519 or
antioxidants such as N-acetylcysteine (Zollner et al, 2002). A po-
tential disadvantage of this approach is its low speci¢city, because
interfering with the pleiotropic e¡ects of NF-kB may have many
other e¡ects on the immune system. Another potential approach
might be inhibition of FucT activity by small-molecule com-
pounds. Because post-translational glycosylation of proteins by
FucTs occurs in the Golgi apparatus, it might, however, be chal-
lenging to ¢nd small molecules penetrating both the cell and the
Golgi membrane. At least two di¡erent companies (Glaxo
SmithKline, Kyowa Hakko Kogyo) have reported recombinant
expression of FucT-VII protein (Shinkai et al, 1997; Smithers
et al, 1997), suggesting that this latter approach is currently used
as recombinant FucT-VII protein is necessary for performing
high-throughput screening. In addition, panosialins A and B
have been isolated as inhibitors of FucT-VII from the culture
broth of Streptomyces sp., which inhibit FucT-VII activity and
cell binding to immobilized selectin ligands in vitro (Shinoda
et al, 1998).
Targeting the second step in the cascade of lymphocyte extra-
vasation also appears very attractive because it has been reported
recently that skin homing of lymphocytes is regulated by either
two (CCR4 and CCR10) or only one chemokine receptor
(CCR10) (Reiss et al, 2001; Homey et al, 2002). Given that many
pharmaceutical companies have a long-standing experience with
the generation of small-molecule inhibitors of chemokine recep-
tor antagonists, and some of these compounds are in late precli-
nical or even early clinical stages (Onu¡er and Horuk, 2002),
inhibition of CCR4 and CCR10 appears attractive and feasible.
Indeed, at least three companies (Millennium, Novartis, and Ser-
ono) report activity in the CCR4 ¢eld (Owen, 2001; Rottman
et al, 2001; Soler et al, 2002). Expression of CCR4 is found on al-
most all CLAþ T cells and is predominantly, albeit not exclu-
sively, expressed on human and murine Th2 cells. Almost all T
cell clones generated from atopy patch tests express CCR4 when
expanded in the presence of antigen plus IL-4 (Biedermann et al,
2002). This observation suggests that interfering with CCR4
using small molecules is attractive especially in Th2-dominated
skin diseases, such as atopic dermatitis.Whether or not inhibition
of CCR10 will be bene¢cial is currently unclear; an antibody
against CCR10 was ine¡ective in one murine model of contact
hypersensitivity, but e¡ective in another when using higher
Table III. Emerging drugs targeting integrin: immunoglobulin superfamily interactions
Target Compound Company Status Targeted indication/comment References
CD11a Efalizumab Genentech/Serono Phase III Moderate to severe psoriasis; humanized Gottlieb et al (2002);
monoclonal antibody against CD11a Papp et al (2001);
subunit of LFA-1 Aru¡o and Hollenbaugh (2001);
IC-747 ICOS Phase II Psoriasis; orally active synthetic compound Gniadecki and Calverley (2002)
able to block LFA-1 and ICAM-1
ICAM-1 Alicaforsen
ISIS-2302
ISIS Phase II Crohn’s disease, rheumatoid arthritis,
psoriasis; antisense phosphothioate
oligonucleotide for topical application in
Crohn’s disease, rheumatoid arthritis,
and psoriasis
Yacyshyn et al (2002);
Maksymowych et al (2002);
Robertson (1997)
VLA-4 Bio1211 Biogen Phase I Small molecule Gniadecki and Calverley (2002);
Antegren/
natalizumab
Biogen/Elan Phase III Multiple sclerosis, Crohn’s disease;
humanized monoclonal antibody against
VLA-4 tested for multiple sclerosis
and Crohn’s disease
Aru¡o and Hollenbaugh (2001);
Shand and Forbes (2003)
LFA-3 Alefacept Biogen Phase III Psoriasis; human recombinant Krueger et al (2002);
LFA-3/IgG1 fusion protein interfering da Silva et al (2002);
Ellis et al (2001)
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concentrations (Reiss et al, 2001; Homey et al, 2002). In addition,
CCR10 is expressed only by a subset of CLAþ cells that are
double negative for CCR7 and CD27 suggesting that they be-
long to the ‘‘e¡ector’’ subpopulation (Soler et al, 2002).
Besides CCR4 and CCR10, thymic stromal lymphopoietin
(TSLP) may be an attractive new target in Th2-dominated skin
in £ammation for several reasons: First,TSLP-activated CD11cþ
dendritic cells prime naive T cells to produce proallergic cyto-
kines such as IL-4, IL-5, and IL-13. Second, TSLP induces the
production of CCL22 (TARC), which may then chemoattract
CCR4-expressingTcells into the skin. Finally,TSLP is expressed
preferentially by lesional keratinocytes from patients with atopic
dermatitis, but not by nonlesional keratinocytes (Leonard, 2002;
Soumelis et al, 2002).Whether blockade of TSLP is of any bio-
logic relevance in Th2-dominated skin diseases remains to be
unraveled.
The third step in the adhesion cascade involves the interaction
of b2-integrins such as LFA-1 (CD11a/CD18) or Mac-1 (CD11b/
CD18) with immunoglobulin superfamily members such as
ICAM-1 orVCAM-1. The ¢rst compounds targeting these mole-
cules are already in clinical trials or entering the clinic such as the
CD11a antagonist efalizumab from Genentech (Gottlieb et al,
2002), IC-747 from ICOS and other compounds summarized in
Table III. In addition to inhibiting T cell recruitment into the
skin, some of these compounds are also inducing apoptosis of
activated T cells (da Silva et al, 2002) or inhibit T cell costimula-
tion (Aru¡o and Hollenbaugh, 2001), which may add to their
clinical e¡ectiveness.
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